Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?

Rotondi M, Coperchini F, Pignatti P, Sideri R, Groppelli G, Leporati P, La Manna L, Magri F, Mariotti S, Chiovato L.

J Clin Endocrinol Metab. 2013 Jan;98(1):308-13. doi: 10.1210/jc.2012-2555. Epub 2012 Nov 1.

PMID:
23118425
[PubMed - indexed for MEDLINE]
2.

Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M, Ferrannini E.

J Clin Endocrinol Metab. 2006 Feb;91(2):614-20. Epub 2005 Nov 22.

PMID:
16303841
[PubMed - indexed for MEDLINE]
3.

Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes.

Rotondi M, Coperchini F, Sideri R, Groppelli G, de Martinis L, Villani L, Pignatti P, Magri F, Chiovato L.

J Interferon Cytokine Res. 2013 Sep;33(9):508-13. doi: 10.1089/jir.2012.0080. Epub 2013 May 15.

PMID:
23675779
[PubMed - indexed for MEDLINE]
4.

Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Santini E, Franceschini SS, Ferrannini E.

J Clin Endocrinol Metab. 2009 May;94(5):1803-9. doi: 10.1210/jc.2008-2450. Epub 2009 Mar 10.

PMID:
19276231
[PubMed - indexed for MEDLINE]
5.

Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.

Crescioli C, Cosmi L, Borgogni E, Santarlasci V, Gelmini S, Sottili M, Sarchielli E, Mazzinghi B, Francalanci M, Pezzatini A, Perigli G, Vannelli GB, Annunziato F, Serio M.

J Endocrinol. 2007 Oct;195(1):145-55.

PMID:
17911406
[PubMed - indexed for MEDLINE]
Free Article
6.

Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.

Antonelli A, Ferrari SM, Frascerra S, Corrado A, Pupilli C, Bernini G, Benvenga S, Ferrannini E, Fallahi P.

Exp Cell Res. 2011 Jul 1;317(11):1527-33. doi: 10.1016/j.yexcr.2011.04.007. Epub 2011 Apr 30.

PMID:
21565188
[PubMed - indexed for MEDLINE]
7.

Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.

Rotondi M, Falorni A, De Bellis A, Laureti S, Ferruzzi P, Romagnani P, Buonamano A, Lazzeri E, Crescioli C, Mannelli M, Santeusanio F, Bellastella A, Serio M.

J Clin Endocrinol Metab. 2005 Apr;90(4):2357-63. Epub 2005 Jan 18.

PMID:
15657375
[PubMed - indexed for MEDLINE]
8.

Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, Lupi C, Minuto M, Berti P, Benvenga S, Basolo F, Orlando C, Miccoli P.

Endocr Relat Cancer. 2009 Dec;16(4):1299-311. doi: 10.1677/ERC-08-0337. Epub 2009 Sep 15.

PMID:
19755523
[PubMed - indexed for MEDLINE]
Free Article
9.

Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Antonelli A, Ferrari SM, Fallahi P, Ghiri E, Crescioli C, Romagnani P, Vitti P, Serio M, Ferrannini E.

Cytokine. 2010 Jun;50(3):260-7. doi: 10.1016/j.cyto.2010.01.009. Epub 2010 Mar 17.

PMID:
20299237
[PubMed - indexed for MEDLINE]
10.

Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.

Antonelli A, Ferrari SM, Fallahi P, Piaggi S, Paolicchi A, Franceschini SS, Salvi M, Ferrannini E.

Metabolism. 2011 Feb;60(2):277-83. doi: 10.1016/j.metabol.2010.02.002. Epub 2010 Mar 6.

PMID:
20206950
[PubMed - indexed for MEDLINE]
11.

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.

Proost P, Struyf S, Loos T, Gouwy M, Schutyser E, Conings R, Ronsse I, Parmentier M, Grillet B, Opdenakker G, Balzarini J, Van Damme J.

Arthritis Res Ther. 2006;8(4):R107.

PMID:
16846531
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.

Borgogni E, Sarchielli E, Sottili M, Santarlasci V, Cosmi L, Gelmini S, Lombardi A, Cantini G, Perigli G, Luconi M, Vannelli GB, Annunziato F, Adorini L, Serio M, Crescioli C.

Endocrinology. 2008 Jul;149(7):3626-34. doi: 10.1210/en.2008-0078. Epub 2008 Mar 27.

PMID:
18372324
[PubMed - indexed for MEDLINE]
13.

Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.

García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M.

J Clin Endocrinol Metab. 2001 Oct;86(10):5008-16.

PMID:
11600578
[PubMed - indexed for MEDLINE]
14.

Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium.

Lombardi A, Cantini G, Mello T, Francalanci M, Gelmini S, Cosmi L, Santarlasci V, Degl'Innocenti S, Luciani P, Deledda C, Annunziato F, Forti G, Galli A, Serio M, Luconi M.

Eur J Cell Biol. 2009 Dec;88(12):731-42. doi: 10.1016/j.ejcb.2009.07.004. Epub 2009 Sep 26.

PMID:
19782427
[PubMed - indexed for MEDLINE]
15.

Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts.

Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.

J Periodontal Res. 2009 Apr;44(2):225-31. doi: 10.1111/j.1600-0765.2008.01124.x. Epub 2008 Oct 7.

PMID:
18973545
[PubMed - indexed for MEDLINE]
16.

β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.

Antonelli A, Ferrari SM, Frascerra S, Ruffilli I, Pupilli C, Bernini G, Sellari-Franceschini S, Gelmini S, Ferrannini E, Fallahi P.

J Endocrinol. 2012 May;213(2):183-91. doi: 10.1530/JOE-11-0488. Epub 2012 Feb 29.

PMID:
22378921
[PubMed - indexed for MEDLINE]
Free Article
17.

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.

Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2. Review.

PMID:
24189283
[PubMed - indexed for MEDLINE]
18.

Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.

Eck M, Schmausser B, Scheller K, Brändlein S, Müller-Hermelink HK.

Clin Exp Immunol. 2003 Dec;134(3):508-15.

PMID:
14632759
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.

Antonelli A, Ferrari SM, Mancusi C, Mazzi V, Pupilli C, Centanni M, Ferri C, Ferrannini E, Fallahi P.

Immunobiology. 2013 May;218(5):690-5. doi: 10.1016/j.imbio.2012.08.267. Epub 2012 Aug 9.

PMID:
22944249
[PubMed - indexed for MEDLINE]
20.

Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis.

Uddin J, Garcia HH, Gilman RH, Gonzalez AE, Friedland JS.

J Immunol. 2005 Sep 1;175(5):3273-81.

PMID:
16116219
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk